Markets
Sheffield Green plans to raise $6.0m in Catalist listing
The company is offering 24.0 million shares.
Sheffield Green plans to raise $6.0m in Catalist listing
The company is offering 24.0 million shares.
Keppel DC REIT's distributable income drops 6.5% YoY to $23.9m in 3Q23
Given the decline, the REIT proposed a 3.6% YoY lower DPU.
CLCT prices $112m worth of FTZ offshore bonds at 3.8%
The bonds are due in three years.
Consumer non-cyclical sector emerges as the most defensive segment in SG
Over the past 10 weeks, 41 stocks in SG generated positive total returns.
Tee International seeks extension to submit revised trading resumption proposal
It requested the extension after signing a second supplemental agreement with Meta5.
SGX makes changes to its board
One of the newest appointees is a former UK lawmaker.
Noontalk’s EGM to be held for proposed adoption of share purchase mandate
It will be conducted on 23 October 2023 at 11 a.m.
What are the 3 factors that steered SG markets in 3Q23?
In 3Q23, the STI generated a 2.1% total return.
Taking ‘overly prescriptive approach’ in encouraging startups to list locally may stifle growth: gov’t
The number of Singapore’s IPOs and proceeds raised has been declining since 2021.
4 directors step down from Charisma Energy’s board
Amongst those who resigned was the company's executive director.
SGX grants Boustead extension following delisting notice
BSL has until 14 November 2023 to comply with SGX’s notice.
Boustead Singapore seeks extension to furnish exit offer proposal
It will provide the details after the release of its 1H24 results.
No Signboard submits revised trading resumption proposal to SGX
Trading of the company’s shares has been suspended since 24 January 2022.
SGX adjusts conversion price of €240m convertible bonds
The adjusted conversion price will be $12.0532.
Offer to take LHN Logistics private closes with 99.14% acceptances
Following the close of the offer, LHN Logistics will be delisted from the Catalist Board of SGX-ST.
OUE Healthcare declares unconditional its offer to delist Healthway Medical
It has received valid acceptances amounting to 2,289,294,145 shares.
SGX orders Boustead Projects to delist
The company failed to restore its public float to at least 10%.
Read Here
Advertise
Sign Up
Commentary
AI is revolutionising learning: Why should educational institutions in Singapore embrace this change?
Seeking an office space in Singapore: Where do you start?